• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.一项比较自体或异基因骨髓移植或强化化疗作为年轻急性髓系白血病患者缓解后治疗的试验的长期随访
Haematologica. 2020 Jan;105(1):e13-e16. doi: 10.3324/haematol.2019.221333. Epub 2019 May 16.
2
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.自体或异基因骨髓移植与急性髓性白血病强化化疗的比较。欧洲癌症研究与治疗组织（EORTC）和意大利成人恶性血液病研究组（GIMEMA）白血病协作组。
N Engl J Med. 1995 Jan 26;332(4):217-23. doi: 10.1056/NEJM199501263320403.
3
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.化疗与自体或异基因骨髓移植在初治缓解期急性髓系白血病治疗中的比较。
N Engl J Med. 1998 Dec 3;339(23):1649-56. doi: 10.1056/NEJM199812033392301.
4
Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.
Eur J Haematol. 1997 Apr;58(4):233-40. doi: 10.1111/j.1600-0609.1997.tb01660.x.
5
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.急性髓系白血病缓解期儿童的异基因骨髓移植、自体骨髓移植及强化化疗的比较
Blood. 2001 Jan 1;97(1):56-62. doi: 10.1182/blood.v97.1.56.
6
Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.首次缓解期急性髓性白血病（AML）中异基因与自体骨髓移植（BMT）对比强化巩固治疗。一项欧洲癌症研究与治疗组织（EORTC）-意大利多中心白血病研究组（GIMEMA）的III期试验（AML8 A）。EORTC白血病协作组和GIMEMA组
Leukemia. 1992;6 Suppl 2:114-5.
7
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.对骨髓增生异常综合征（MDS）及继发于MDS的急性髓系白血病患者进行强化化疗，随后进行异基因或自体干细胞移植。
Blood. 2001 Oct 15;98(8):2326-31. doi: 10.1182/blood.v98.8.2326.
8
Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.强化定时诱导治疗后行自体或异基因骨髓移植治疗儿童急性髓系白血病或骨髓增生异常综合征：儿童癌症研究组的一项试点研究。
J Clin Oncol. 1993 Aug;11(8):1448-57. doi: 10.1200/JCO.1993.11.8.1448.
9
Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.异基因与自体骨髓移植对比化疗治疗首次完全缓解的急性髓系白血病（BGM 84和BGMT 87研究）。BGMT研究组
Bone Marrow Transplant. 1991;7 Suppl 2:36.
10
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).成人急性髓系白血病强化诱导化疗后进行大剂量化疗及自体外周血干细胞移植：东部肿瘤协作组试验（E4995）
Leuk Lymphoma. 2005 Jan;46(1):55-61. doi: 10.1080/10428190412331283288.

引用本文的文献

1
Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia.自体造血细胞移植、匹配同胞供者造血细胞移植与化疗在低危和中危急性髓系白血病患者中的比较。
Front Immunol. 2025 Jan 8;15:1511057. doi: 10.3389/fimmu.2024.1511057. eCollection 2024.
2
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.依托泊苷联合阿糖胞苷与环磷酰胺或美法仑用于急性髓系白血病首次完全缓解期成人患者基于白消安的自体干细胞移植预处理方案：欧洲血液与骨髓移植协会急性白血病工作组的一项研究
Bone Marrow Transplant. 2023 Nov;58(11):1197-1202. doi: 10.1038/s41409-023-02075-4. Epub 2023 Aug 8.
3
Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores.重症同种异体移植患者预后指数（PICAT）和序贯器官衰竭评估（SOFA）评分可预测接受重症监护的异基因干细胞移植患者的总生存率。
Cancers (Basel). 2022 Aug 31;14(17):4266. doi: 10.3390/cancers14174266.
4
Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective.单倍体相合干细胞移植治疗急性髓系白血病：当前疗法、挑战与未来展望
Front Oncol. 2021 Oct 28;11:758512. doi: 10.3389/fonc.2021.758512. eCollection 2021.
5
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.异基因造血干细胞移植受者对 BNT162b2 疫苗的中和抗体反应的预测因素。
J Hematol Oncol. 2021 Oct 24;14(1):174. doi: 10.1186/s13045-021-01190-3.
6
Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation consolidation chemotherapy.急性髓系白血病缓解后策略的比较：自体造血干细胞移植与巩固化疗。
Hematol Rep. 2020 Dec 2;12(3):8380. doi: 10.4081/hr.2020.8380.
7
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.13项欧洲癌症研究与治疗组织-意大利成人血液学和肿瘤学协作组-荷兰成人血液学和肿瘤学协作组试验中纳入的960例继发性急性髓系白血病患者的生存随时间的改善情况。
Cancers (Basel). 2020 Nov 11;12(11):3334. doi: 10.3390/cancers12113334.
8
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT.在孤立性8号染色体三体的急性髓系白血病患者中，异基因造血干细胞移植的无白血病生存率优于自体造血干细胞移植：来自欧洲血液与骨髓移植协会急性白血病工作组的一项研究
Bone Marrow Transplant. 2021 Feb;56(2):461-469. doi: 10.1038/s41409-020-01051-6. Epub 2020 Sep 4.

本文引用的文献

1
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.成人急性髓系白血病患者自体造血干细胞移植后复发行异基因造血干细胞移植：来自 EBMT 急性白血病工作组的 537 例患者的回顾性分析。
Am J Hematol. 2018 Dec;93(12):1532-1542. doi: 10.1002/ajh.25285. Epub 2018 Oct 26.
2
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT.优化急性髓系白血病自体干细胞移植的预处理方案：高危患者在首次完全缓解时自体移植中，与环磷酰胺相比，白消安和马法兰的结果更好：来自 EBMT 急性白血病工作组的研究。
Am J Hematol. 2018 Jul;93(7):859-866. doi: 10.1002/ajh.25105. Epub 2018 Apr 28.
3
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.急性髓系白血病中的微小残留病：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12.
4
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission.在首次分子缓解的成人低危和中危急性髓细胞白血病患者中，无关供者与自体移植的比较。
Am J Hematol. 2017 Dec;92(12):1318-1323. doi: 10.1002/ajh.24904. Epub 2017 Sep 28.
5
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
6
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.NPM1 和 FLT3-ITD 等位基因比分类的细胞遗传学正常 AML 缓解后治疗的比较价值。
Leukemia. 2017 Jan;31(1):26-33. doi: 10.1038/leu.2016.183. Epub 2016 Jun 24.
7
Hematopoietic stem cell transplantation for patients with AML in first complete remission.造血干细胞移植治疗首次完全缓解的 AML 患者。
Blood. 2016 Jan 7;127(1):62-70. doi: 10.1182/blood-2015-07-604546. Epub 2015 Dec 10.
8
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.急性髓系白血病首次缓解期采集的大量动员CD34+细胞与高复发风险相关，无论是否接受自体外周血干细胞移植或自体骨髓移植治疗。
Bone Marrow Transplant. 2015 Mar;50(3):341-7. doi: 10.1038/bmt.2014.262. Epub 2014 Nov 17.
9
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.自体外周血造血干细胞移植治疗急性髓细胞白血病。
Blood. 2011 Dec 1;118(23):6037-42. doi: 10.1182/blood-2011-07-370247. Epub 2011 Sep 27.
10
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后的长期生存和晚期死亡。
J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

作者信息

Baron Frédéric, Efficace Fabio, Cannella Laura, Willemze Roel, Vignetti Marco, Muus Petra, Marie Jean-Pierre, Ferrero Dario, Fazi Paola, La Sala Edoardo, Bourhis Jean-Henri, Fabbiano Francesco, Bosi Alberto, Sborgia Marco, Martinelli Giovanni, Wittnebel Sebastian, Trisolini Silvia, Petti Maria Concetta, Halkes Constantijn J M, van der Velden Walter J F M, de Witte Theo, Amadori Sergio, Zittoun Robert A, Suciu Stefan

机构信息

GIGA-I3 and CHU, University of Liège, Liège, Belgium

Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Rome, Italy.

出版信息

Haematologica. 2020 Jan;105(1):e13-e16. doi: 10.3324/haematol.2019.221333. Epub 2019 May 16.

DOI:10.3324/haematol.2019.221333
PMID:31097634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6939505/
Abstract
摘要